Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

HHS Official Says The Agency Has Responded To Every State That Has Requested "Surge Sites" For Covid-19 Testing - Press Call

11/16/2020 | 12:36pm EST

Nov 16 (Reuters) - Abbott Laboratories:

* HHS' BRETT GIROIR SAYS WILL BE SENDING OVER 8 MILLION OF ABBOTT'S BINAXNOW TESTS TO THE STOCKPILE THIS WEEK - PRESS CALL

* HHS OFFICIAL SAYS TESTING COMPANIES TELLING HIM THEY ARE "IN GOOD SHAPE" WHEN IT COMES TO BASIC SUPPLIES NEEDED TO PERFORM COVID-19 TESTING - PRESS CALL

* HHS OFFICIAL SAYS THE AGENCY HAS RESPONDED TO EVERY STATE THAT HAS REQUESTED "SURGE SITES" FOR COVID-19 TESTING - PRESS CALL

* HHS OFFICIAL SAYS THE AGENCY HAS GONE TO 17 STATES AND OVER 500 LOCATIONS TO PERFORM SURGE TESTING FOR COVID-19 - PRESS CALL Further company coverage:


© Reuters 2020
All news about ABBOTT LABORATORIES
01/15ABBOTT LABORATORIES : To launch the neurosphere mypath digital health app design..
AQ
01/14ABBOTT : to Launch the NeuroSphere™ myPath™ Digital Health App Desig..
PR
01/14ABBOTT LABORATORIES : Ex-dividend day for
FA
01/13ABBOTT LABORATORIES : Announces fulfillment of federal government purchase of 15..
AQ
01/12ABBOTT LABORATORIES : Fulfills US Government's Order of 150 Million BinaxNOW COV..
MT
01/12ABBOTT : Announces Fulfillment of Federal Government Purchase of 150 Million Bin..
PR
01/11ABBOTT LABORATORIES : Receives FDA 510(k) Clearance for Rapid Handheld Blood Tes..
MT
01/11ABBOTT : Receives FDA 510(k) Clearance for the First Rapid Handheld Blood Test f..
PR
01/06ABBOTT : Hosts Conference Call for Fourth-Quarter Earnings
PR
2020ABBOTT LABORATORIES : - as vaccines roll out, americans see covid-19 testing as ..
AQ
More news
Financials (USD)
Sales 2020 33 854 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 794 M - -
P/E ratio 2020 45,4x
Yield 2020 1,29%
Capitalization 191 B 191 B -
EV / Sales 2020 5,98x
EV / Sales 2021 5,19x
Nbr of Employees 107 000
Free-Float 88,9%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 120,22 $
Last Close Price 111,30 $
Spread / Highest target 21,3%
Spread / Average Target 8,02%
Spread / Lowest Target -26,3%
EPS Revisions
Managers and Directors
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES1.65%190 701
MEDTRONIC PLC-0.28%157 229
BECTON, DICKINSON AND COMPANY4.60%76 127
HOYA CORPORATION-2.28%50 080
ALIGN TECHNOLOGY, INC.6.15%44 726
BAXTER INTERNATIONAL INC.-0.25%40 886